This Harvard program takes a rigorous approach to psychedelic-assisted psychotherapy, examining the real clinical complexities that practitioners must navigate.
Key Topics
- Pharmacology of psilocybin, MDMA, and ketamine
- Patient selection and contraindications
- Integration therapy frameworks
- Adverse event management
- Applications in PTSD, depression, and addiction
Target Audience
Psychiatrists, psychologists, neurologists, and mental health professionals.
